Literature DB >> 30226727

At-a-glance - Concurrent monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova Scotia, Canada.

Emily Schleihauf1, Kirstin Crabtree2, Carolyn Dohoo3, Sarah Fleming4, Heather McPeake2, Matthew Bowes5.   

Abstract

Timely public health surveillance is required to understand trends in opioid use and harms. Here, opioid dispensing data from the Nova Scotia Prescription Monitoring Program are presented alongside fatality data from the Nova Scotia Medical Examiner Service. Concurrent monitoring of trends in these data sources is essential to detect population-level effects (whether intended or unintended) of interventions related to opioid prescribing.

Entities:  

Keywords:  coroners and medical examiners; opioid-related disorders; prescription drug monitoring programs; public health surveillance

Mesh：

Substances：

Year:  2018        PMID： 30226727      PMCID： PMC6169707          DOI： 10.24095/hpcdp.38.9.05

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN： 2368-738X            Impact factor:   3.240


  14 in total

1.  Geographical variation in opioid prescribing and opioid-related mortality in Ontario.

Authors:  Tara Gomes; David Juurlink; Rahim Moineddin; Piotr Gozdyra; Irfan Dhalla; Michael Paterson; Muhammad Mamdani
Journal:  Healthc Q       Date:  2011

2.  Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.

Authors:  Benedikt Fischer; Jürgen Rehm; Mark Tyndall
Journal:  CMAJ       Date:  2016-11-07       Impact factor: 8.262

3.  High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.

Authors:  Benedikt Fischer; Wayne Jones; Jürgen Rehm
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-14       Impact factor: 2.890

Review 4.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

5.  Ten Steps the Federal Government Should Take Now to Reverse the Opioid Addiction Epidemic.

Authors:  Andrew Kolodny; Thomas R Frieden
Journal:  JAMA       Date:  2017-10-24       Impact factor: 56.272

6.  Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis.

Authors:  Tara Gomes; Andrea Mastorakos; J Michael Paterson; Ingrid Sketris; Patricia Caetano; Simon Greaves; David Henry
Journal:  CMAJ Open       Date:  2017-11-22

7.  An emergency response to the opioid overdose crisis in Canada: a regulated opioid distribution program.

Authors:  Mark Tyndall
Journal:  CMAJ       Date:  2018-01-15       Impact factor: 8.262

8.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

9.  Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey.

Authors:  Katherine Hempstead; Emel O Yildirim
Journal:  Health Econ       Date:  2013-06-06       Impact factor: 3.046

10.  Guideline for opioid therapy and chronic noncancer pain.

Authors:  Jason W Busse; Samantha Craigie; David N Juurlink; D Norman Buckley; Li Wang; Rachel J Couban; Thomas Agoritsas; Elie A Akl; Alonso Carrasco-Labra; Lynn Cooper; Chris Cull; Bruno R da Costa; Joseph W Frank; Gus Grant; Alfonso Iorio; Navindra Persaud; Sol Stern; Peter Tugwell; Per Olav Vandvik; Gordon H Guyatt
Journal:  CMAJ       Date:  2017-05-08       Impact factor: 8.262
View more
  5 in total

1.  Commentary - Broadening our understanding of Canada's epidemics of pharmaceutical and contaminated street drug opioid-related overdoses.

Authors:  Robert Strang
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-09       Impact factor: 3.240

2.  Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis.

Authors:  Thomas D Brothers; Kimiko Mosseler; Susan Kirkland; Patti Melanson; Lisa Barrett; Duncan Webster
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

3.  Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness.

Authors:  Thomas D Brothers; Malcolm Leaman; Matthew Bonn; Dan Lewer; Jacqueline Atkinson; John Fraser; Amy Gillis; Michael Gniewek; Leisha Hawker; Heather Hayman; Peter Jorna; David Martell; Tiffany O'Donnell; Helen Rivers-Bowerman; Leah Genge
Journal:  Drug Alcohol Depend       Date:  2022-04-07       Impact factor: 4.852

4.  Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province.

Authors:  Joseph Sadek; Joseph Saunders
Journal:  BMC Psychiatry       Date:  2022-07-30       Impact factor: 4.144

5.  Problematic Opioid Use: A Scoping Literature Review of Profiles.

Authors:  Léonie Archambault; Karine Bertrand; Michel Perreault
Journal:  Subst Abuse       Date:  2022-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.